General
Novo Nordisk CEO Lars Fruergaard Jorgensen to resign as Ozempic faces stiff competition
The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down following a plunge in the company’s share price, the drug maker said on Friday.
The company said it was searching for a successor for Lars Fruergaard Jorgensen, who has held the…
Continue Reading
-
Noosa News13 hours agoPrincess Anne visits Gallipoli Barracks in Brisbane on Remembrance Day as Australian tour ends
-
General10 hours agoCar bomb outside Islamabad court kills at least five, Pakistani media says
-
Noosa News12 hours agoRoyal visit to Gallipoli Barracks in Enoggera on Remembrance Day
-
General14 hours ago‘Do you care?’: Coles stares down anti-salmon activists